Granted Patent B2

US 12,569,628 · App. 18/301,118 · Granted Mar 10, 2026

Inventors: Wolfgang Scholz (Beverly, MA); Gregory W. Hall (Belmont, MA); Jacob Naroian (Winchester, MA)

Assignee: Third Pole, Inc.

A61M13/003A61M3/005A61M11/00A61M35/30B01F23/237A61K9/51A61M2005/006A61M2202/00A61M2202/0007A61M2202/0208A61M2202/0216A61M2202/0225A61M2202/0233A61M2202/0241A61M2202/0266A61M2202/0275A61M2202/0283A61M2202/0291A61M2205/07A61M2205/3606A61M2206/20B01F23/2373B01F23/2376B01F23/23765

Abstract

Claims (33)

1 . A nanobubble generation system for generating a medicinal solution, comprising:

a reservoir configured to store a liquid;

a source of medicinal gas;

a pump configured to propel the liquid from the reservoir;

a nanobubble generator in the form of a venturi and in fluid communication with the reservoir and the source of medicinal gas, the nanobubble generator configured to form a nanobubble solution comprising nanobubbles of the medicinal gas in the liquid;

a return flow path configured to deliver the nanobubble solution exiting the nanobubble generator to the reservoir such that the nanobubble solution passes through the nanobubble generator and the reservoir a plurality of times; and

a controller configured to modulate a concentration of nanobubbles in the nanobubble solution using one or more inputs, the one or more inputs comprising the plurality of times the nanobubble solution passes through the return flow path.

2 . The system of claim 1 , further comprising a delivery device configured to deliver a portion of the nanobubble solution exiting the reservoir to a target tissue to treat a medical condition in a patient.

3 . The system of claim 2 , wherein the delivery device comprises a syringe port, a syringe, a needle, and a catheter to deliver the nanobubble solution to the target tissue.

4 . The system of claim 1 , wherein the pump is at least one of a peristaltic pump, a syringe pump, a screw pump, a gear pump, and a diaphragm pump.

5 . The system of claim 1 , wherein the reservoir is removable.

6 . The system of claim 1 , wherein the reservoir is in the form of a bag.

7 . The system of claim 1 , wherein the liquid is in the form of at least one of an aqueous solution, a lipid, and an alcohol.

8 . The system of claim 1 , wherein the liquid is at least one of sesame oil, silicone oil, mineral oil, ethanol, isopropyl alcohol, heparin, saline, heparinized saline, lactated Ringer's solution, phosphate-buffered saline, and biological fluids.

9 . The system of claim 1 , wherein the liquid includes a pH buffer.

10 . The system of claim 1 , wherein the gas is one or more of nitric oxide, carbon monoxide, carbon dioxide, ozone, oxygen, helium, nitrogen, nitrous oxide, argon, xenon, and an anesthetic.

11 . The system of claim 1 , wherein the one or more inputs comprises one or more of temperature, a concentration of the gas, pH of the liquid, a flow rate of the liquid, pressure of the medicinal gas from the source, pressure of gas in the reservoir, quantity of gas added to the liquid, viscosity of the liquid, time since nanobubble solution creation, nanobubble generator operating time, and osmolality.

12 . The system of claim 1 , wherein a dose of nanobubble solution is configured to be modulated by one or more of a quantity of dissolved and nanobubble gas in the liquid and the quantity of liquid delivered.

13 . The system of claim 1 , wherein the nanobubble solution is configured to be removed from the system intermittently.

14 . The system of claim 1 , wherein the nanobubble solution is configured to be removed from the system continuously.

15 . The system of claim 1 , further comprising a flow path configured to vent excess gas from the system.

16 . The system of claim 1 , further comprising a scrubber configured to scrub excess gas before release from the system.

17 . The system of claim 16 , further comprising one or more of a valve and a pump to control a flow of the excess gas through a vent.

18 . The system of claim 1 , wherein a molarity of the gas in the liquid is from about 0.1 mM to 3 mM.

19 . The system of claim 1 , further comprising a temperature modulation component configured to chill at least one of the liquid upstream of the nanobubble generator, the nanobubble solution downstream of the nanobubble generator, and the liquid reservoir.

20 . The system of claim 1 , wherein the nanobubble solution is configured to be used to treat a medical condition, the medical condition being at least one of cancer, open wound, urinary tract infection, eye infection, organ transplant, skin graft, fungal infection, bacterial infection, viral infection, kidney disease, diabetes, myocardial infarct, stroke, atherosclerotic lesion, thrombus, blood disease, hair loss, and vasospasm.

21 . A nanobubble generation system for generating a medicinal solution, comprising:

a reservoir configured to store a liquid;

a source of medicinal gas;

a nanobubble generator in fluid communication with the reservoir and the source of medicinal gas, the nanobubble generator configured to form a nanobubble solution of nanobubbles of the medicinal gas in the liquid;

a return flow path configured to deliver the nanobubble solution exiting the nanobubble generator to the reservoir such that the nanobubble solution passes through the nanobubble generator and the reservoir a plurality of times; and

a controller configured to modulate a concentration of nanobubbles in the nanobubble solution using one or more inputs, the one or more inputs comprising the plurality of times the nanobubble solution passes through the return flow path,

wherein at least a portion of the nanobubble solution is configured to be used to one or more of prevent and treat a vasospasm in a blood vessel.

Assignments (2)

Continuity (4)

References Cited (400)

Cited By (1)

US 12,691,234